Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.

Autor: Mendes Paranhos AC; Tropical Medicine Center, Federal University of Pará, Belém, Brazil.; Biological and Health Center, Pará State University, Belém, Brazil., Nazareth Dias ÁR; Biological and Health Center, Pará State University, Belém, Brazil., Machado da Silva LC; Biological and Health Center, Pará State University, Belém, Brazil., Vieira Hennemann Koury G; Biological and Health Center, Pará State University, Belém, Brazil., de Jesus Sousa E; Biological and Health Center, Pará State University, Belém, Brazil., Cerasi AJ Jr; Biological Science Center, Federal University of Pará, Belém, Brazil.; Cosmopolita College, Belém, Brazil., Souza GS; Tropical Medicine Center, Federal University of Pará, Belém, Brazil.; Biological Science Center, Federal University of Pará, Belém, Brazil., Simões Quaresma JA; Tropical Medicine Center, Federal University of Pará, Belém, Brazil.; Biological and Health Center, Pará State University, Belém, Brazil., Magno Falcão LF; Biological and Health Center, Pará State University, Belém, Brazil.; University of São Paulo, São Paulo, Brazil.
Jazyk: angličtina
Zdroj: JAMA network open [JAMA Netw Open] 2022 Sep 01; Vol. 5 (9), pp. e2230637. Date of Electronic Publication: 2022 Sep 01.
DOI: 10.1001/jamanetworkopen.2022.30637
Abstrakt: Importance: Determining the characteristics, type, and severity of olfactory dysfunction in patients with long COVID is important for the prognosis and potential treatment of the affected population.
Objective: To describe the sociodemographic and clinical features of patients with long COVID who develop persistent olfactory dysfunction.
Design, Setting, and Participants: This cross-sectional study, conducted at a rehabilitation center at a public university in the Amazon region of Brazil between September 9, 2020, and October 20, 2021, comprised 219 patients with long COVID and self-reported neurologic symptoms. Of these 219 patients, 139 received a diagnosis of chronic olfactory dysfunction, as confirmed by the Connecticut Chemosensory Clinical Research Center (CCCRC) test.
Exposure: Clinical diagnosis of long COVID.
Main Outcomes and Measures: Electronic case report forms were prepared for the collection of sociodemographic and clinical data. Patients' sense of smell was evaluated via a CCCRC test, and the association of olfactory dysfunction with aspects of daily life was recorded using a questionnaire.
Results: Of the 219 patients included in the study, 164 (74.9%) were women, 194 (88.6%) were between 18 and 59 years of age (mean [SD] age, 43.2 [12.9] years), 206 (94.1%) had more than 9 years of education, and 115 (52.5%) had a monthly income of up to US $192.00. In the study group, 139 patients (63.5%) had some degree of olfactory dysfunction, whereas 80 patients (36.5%) had normosmia. Patients with olfactory dysfunction had a significantly longer duration of long COVID symptoms than those in the normosmia group (mean [SD], 242.7 [101.9] vs 221.0 [97.5] days; P = .01). Among patients with anosmia, there was a significant association between olfactory dysfunction and daily activities, especially in terms of impairment in hazard detection (21 of 31 patients [67.7%]), personal hygiene (21 of 31 patients [67.7%]), and food intake (21 of 31 patients [67.7%]). Univariable logistic regression analyses found that ageusia symptoms were associated with the occurrence of olfactory dysfunction (odds ratio [OR], 11.14 [95% CI, 4.76-26.07]; P < .001), whereas headache (OR, 0.41 [95% CI, 0.22-0.76]; P < .001) and sleep disorders (OR, 0.48 [95% CI, 0.26-0.92]; P = .02) showed an inverse association with the occurrence of olfactory dysfunction.
Conclusions and Relevance: Olfactory dysfunction is one of the most important long-term neurologic symptoms of COVID-19, with the highest prevalence seen among women, adults, and outpatients. Patients with olfactory dysfunction may experience persistent severe hyposmia or anosmia more than 1 year from the onset of symptoms, suggesting the possibility of the condition becoming a permanent sequela.
Databáze: MEDLINE